Published 5 January 2004. doi:10.1084/jem.20030451
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 199, Number 1, 125-130
Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris
Edmund Lee1,
William L. Trepicchio3,
Judith L. Oestreicher4,
Debra Pittman4,
Frank Wang1,
Francesca Chamian1,
Madhav Dhodapkar2 and
James G. Krueger1
1 Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY 10021
2 Laboratory for Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021
3 Millennium Pharmaceuticals, Clinical Research-Pharmacogenomics, Cambridge, MA 02139
4 Wyeth, Andover, MA 01810
Address correspondence to Edmund Lee or James G. Krueger, Laboratory for Investigative Dermatology, The Rockefeller University Hospital, P.O. Box 178, 1230 York Avenue, New York, NY 10021. Phone: (212) 327-7017; Fax: (212) 327-8232; email: leee{at}rockefeller.edu
Psoriasis is a type Ideviated disease characterized by the presence of interferon (IFN)-
and multiple IFN-related inflammatory genes in lesions. Because interleukin (IL)-23 is now recognized to play a role in the recruitment of inflammatory cells in a T helper cell (Th)1-mediated disease, we examined psoriasis skin lesions for production of this newly described cytokine. IL-23 is composed of two subunits: a unique p19 subunit and a p40 subunit shared with IL-12. We found a reliable increase in p19 mRNA by quantitative reverse transcription polymerase chain reaction in lesional skin compared with nonlesional skin (22.3-fold increase; P = 0.001). The p40 subunit, shared by IL-12 and IL-23, increased by 11.6-fold compared with nonlesional skin (P = 0.003), but the IL-12 p35 subunit was not increased in lesional skin. IL-23 was expressed mainly by dermal cells and increased p40 immunoreactivity was visualized in large dermal cells in the lesions. Cell isolation experiments from psoriatic tissue showed strong expression of p19 mRNA in cells expressing monocyte (CD14+ CD11c+ CD83-) and mature dendritic cell (DC) markers (CD14- CD11c+ CD83+), whereas in culture, the mRNAs for p40 and p19 were strongly up-regulated in stimulated monocytes and monocyte-derived DCs, persisting in the latter for much longer periods than IL-12. Our data suggest that IL-23 is playing a more dominant role than IL-12 in psoriasis, a Th1 type of human inflammatory disease.
Key Words: cytokines gene expression dendritic cell IL-23 Th1 cells
Abbreviation used in this paper: hARP, human acidic ribosomal protein gene.
The online version of this article contains supplemental material.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Hillyer, P., Larche, M. J., Bowman, E. P., McClanahan, T. K., de Waal Malefyt, R., Schewitz, L. P., Giddins, G., Feldmann, M., Kastelein, R. A., Brennan, F. M.
(2009). Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis. Rheumatology (Oxford)
0: kep293v1-kep293
[Abstract]
[Full Text]
-
Chino, T., Draves, K. E., Clark, E. A.
(2009). Regulation of dendritic cell survival and cytokine production by osteoprotegerin. J. Leukoc. Biol.
86: 933-940
[Abstract]
[Full Text]
-
Wang, H., Syrovets, T., Kess, D., Buchele, B., Hainzl, H., Lunov, O., Weiss, J. M., Scharffetter-Kochanek, K., Simmet, T.
(2009). Targeting NF-{kappa}B with a Natural Triterpenoid Alleviates Skin Inflammation in a Mouse Model of Psoriasis. J. Immunol.
183: 4755-4763
[Abstract]
[Full Text]
-
Jang, M. S., Son, Y. M., Kim, G. R., Lee, Y. J., Lee, W. K., Cha, S. H., Han, S. H., Yun, C.-H.
(2009). Synergistic production of interleukin-23 by dendritic cells derived from cord blood in response to costimulation with LPS and IL-12. J. Leukoc. Biol.
86: 691-699
[Abstract]
[Full Text]
-
LOFFREDO, S., AYALA, F., MARONE, G., DELFINO, G., STRANGES, S., MARONE, G.
(2009). Immunopathogenesis of Psoriasis and Pharmacological Perspectives. The Journal of Rheumatology Supplement
83: 9-11
[Abstract]
[Full Text]
-
ROBINSON, H., KELLY, S., PITZALIS, C.
(2009). Basic Synovial Biology and Immunopathology in Psoriatic Arthritis. The Journal of Rheumatology Supplement
83: 14-16
[Abstract]
[Full Text]
-
Nestle, F. O., Kaplan, D. H., Barker, J.
(2009). Psoriasis. NEJM
361: 496-509
[Full Text]
-
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., Lubberts, E.
(2009). Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis. J. Immunol.
182: 5836-5845
[Abstract]
[Full Text]
-
Nair, R. P., Ding, J., Duffin, K. C., Helms, C., Voorhees, J. J., Krueger, G. G., Bowcock, A. M., Abecasis, G. R., Elder, J. T.
(2009). Psoriasis Bench to Bedside: Genetics Meets Immunology. Arch Dermatol
145: 462-464
[Full Text]
-
Mathers, A. R., Janelsins, B. M., Rubin, J. P., Tkacheva, O. A., Shufesky, W. J., Watkins, S. C., Morelli, A. E., Larregina, A. T.
(2009). Differential Capability of Human Cutaneous Dendritic Cell Subsets to Initiate Th17 Responses. J. Immunol.
182: 921-933
[Abstract]
[Full Text]
-
Liu, Y., Yuan, Y., Li, Y., Zhang, J., Xiao, G., Vodovotz, Y., Billiar, T. R., Wilson, M. A., Fan, J.
(2009). Interacting Neuroendocrine and Innate and Acquired Immune Pathways Regulate Neutrophil Mobilization from Bone Marrow following Hemorrhagic Shock. J. Immunol.
182: 572-580
[Abstract]
[Full Text]
-
Bosisio, D., Vulcano, M., Del Prete, A., Sironi, M., Salvi, V., Salogni, L., Riboldi, E., Leoni, F., Dinarello, C. A., Girolomoni, G., Sozzani, S.
(2008). Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. J. Leukoc. Biol.
84: 1540-1548
[Abstract]
[Full Text]
-
Kobayashi, T, Okamoto, S, Hisamatsu, T, Kamada, N, Chinen, H, Saito, R, Kitazume, M T, Nakazawa, A, Sugita, A, Koganei, K, Isobe, K, Hibi, T
(2008). IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut
57: 1682-1689
[Abstract]
[Full Text]
-
Guttman-Yassky, E., Lowes, M. A., Fuentes-Duculan, J., Zaba, L. C., Cardinale, I., Nograles, K. E., Khatcherian, A., Novitskaya, I., Carucci, J. A., Bergman, R., Krueger, J. G.
(2008). Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis. J. Immunol.
181: 7420-7427
[Abstract]
[Full Text]
-
Danilenko, D. M.
(2008). Review Paper: Preclinical Models of Psoriasis. Vet Pathol
45: 563-575
[Abstract]
[Full Text]
-
Jasny, E., Eisenblatter, M., Matz-Rensing, K., Tenner-Racz, K., Tenbusch, M., Schrod, A., Stahl-Hennig, C., Moos, V., Schneider, T., Racz, P., Uberla, K., Kaup, F.-J., Ignatius, R.
(2008). IL-12-Impaired and IL-12-Secreting Dendritic Cells Produce IL-23 upon CD154 Restimulation. J. Immunol.
180: 6629-6639
[Abstract]
[Full Text]
-
Kimball, A. B., Gordon, K. B., Langley, R. G., Menter, A., Chartash, E. K., Valdes, J., for the ABT-874 Psoriasis Study Investigators,
(2008). Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis: Results of a Randomized, Placebo-Controlled, Phase 2 Trial. Arch Dermatol
144: 200-207
[Abstract]
[Full Text]
-
Haider, A. S., Lowes, M. A., Suarez-Farinas, M., Zaba, L. C., Cardinale, I., Khatcherian, A., Novitskaya, I., Wittkowski, K. M., Krueger, J. G.
(2008). Identification of Cellular Pathways of "Type 1," Th17 T Cells, and TNF- and Inducible Nitric Oxide Synthase-Producing Dendritic Cells in Autoimmune Inflammation through Pharmacogenomic Study of Cyclosporine A in Psoriasis. J. Immunol.
180: 1913-1920
[Abstract]
[Full Text]
-
Arakura, F., Hida, S., Ichikawa, E., Yajima, C., Nakajima, S., Saida, T., Taki, S.
(2007). Genetic Control Directed toward Spontaneous IFN-{alpha}/IFN-beta Responses and Downstream IFN-{gamma} Expression Influences the Pathogenesis of a Murine Psoriasis-Like Skin Disease. J. Immunol.
179: 3249-3257
[Abstract]
[Full Text]
-
Sa, S. M., Valdez, P. A., Wu, J., Jung, K., Zhong, F., Hall, L., Kasman, I., Winer, J., Modrusan, Z., Danilenko, D. M., Ouyang, W.
(2007). The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis. J. Immunol.
178: 2229-2240
[Abstract]
[Full Text]
-
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., Lebwohl, M., the CNTO 1275 Psoriasis Study Group,
(2007). A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis. NEJM
356: 580-592
[Abstract]
[Full Text]
-
Li, Y., Chu, N., Hu, A., Gran, B., Rostami, A., Zhang, G.-X.
(2007). Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain
130: 490-501
[Abstract]
[Full Text]
-
Wada, Y., Lu, R., Zhou, D., Chu, J., Przewloka, T., Zhang, S., Li, L., Wu, Y., Qin, J., Balasubramanyam, V., Barsoum, J., Ono, M.
(2007). Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor. Blood
109: 1156-1164
[Abstract]
[Full Text]
-
Kim, H.-R., Cho, M.-L., Kim, K.-W., Juhn, J.-Y., Hwang, S.-Y., Yoon, C.-H., Park, S.-H., Lee, S.-H., Kim, H.-Y.
(2007). Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-{kappa}B- and p38 MAPK-dependent signalling pathways. Rheumatology (Oxford)
46: 57-64
[Abstract]
[Full Text]
-
Chan, J. R., Blumenschein, W., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S., Lucian, L., Geissler, R., Brodie, S., Kimball, A. B., Gorman, D. M., Smith, K., de Waal Malefyt, R., Kastelein, R. A., McClanahan, T. K., Bowman, E. P.
(2006). IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. JEM
203: 2577-2587
[Abstract]
[Full Text]
-
Leon, F., Contractor, N., Fuss, I., Marth, T., Lahey, E., Iwaki, S., la Sala, A., Hoffmann, V., Strober, W., Kelsall, B. L.
(2006). Antibodies to Complement Receptor 3 Treat Established Inflammation in Murine Models of Colitis and a Novel Model of Psoriasiform Dermatitis. J. Immunol.
177: 6974-6982
[Abstract]
[Full Text]
-
Toichi, E., Torres, G., McCormick, T. S., Chang, T., Mascelli, M. A., Kauffman, C. L., Aria, N., Gottlieb, A. B., Everitt, D. E., Frederick, B., Pendley, C. E., Cooper, K. D.
(2006). An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis. J. Immunol.
177: 4917-4926
[Abstract]
[Full Text]
-
Vaknin-Dembinsky, A., Balashov, K., Weiner, H. L.
(2006). IL-23 Is Increased in Dendritic Cells in Multiple Sclerosis and Down-Regulation of IL-23 by Antisense Oligos Increases Dendritic Cell IL-10 Production.. J. Immunol.
176: 7768-7774
[Abstract]
[Full Text]
-
Piskin, G., Sylva-Steenland, R. M. R., Bos, J. D., Teunissen, M. B. M.
(2006). In Vitro and In Situ Expression of IL-23 by Keratinocytes in Healthy Skin and Psoriasis Lesions: Enhanced Expression in Psoriatic Skin. J. Immunol.
176: 1908-1915
[Abstract]
[Full Text]
-
Yamanaka, K.-i., Clark, R., Dowgiert, R., Hurwitz, D., Shibata, M., Rich, B. E., Hirahara, K., Jones, D. A., Eapen, S., Mizutani, H., Kupper, T. S.
(2006). Expression of Interleukin-18 and Caspase-1 in Cutaneous T-Cell Lymphoma. Clin. Cancer Res.
12: 376-382
[Abstract]
[Full Text]
-
Lowes, M. A., Chamian, F., Abello, M. V., Fuentes-Duculan, J., Lin, S.-L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Wittkowski, K. M., Papp, K., Garovoy, M., Dummer, W., Steinman, R. M., Krueger, J. G.
(2005). Increase in TNF-{alpha} and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. USA
102: 19057-19062
[Abstract]
[Full Text]
-
Morelli, A. E., Rubin, J. P., Erdos, G., Tkacheva, O. A., Mathers, A. R., Zahorchak, A. F., Thomson, A. W., Falo, L. D. Jr., Larregina, A. T.
(2005). CD4+ T Cell Responses Elicited by Different Subsets of Human Skin Migratory Dendritic Cells. J. Immunol.
175: 7905-7915
[Abstract]
[Full Text]
-
Gottlieb, A. B., Chamian, F., Masud, S., Cardinale, I., Abello, M. V., Lowes, M. A., Chen, F., Magliocco, M., Krueger, J. G.
(2005). TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques. J. Immunol.
175: 2721-2729
[Abstract]
[Full Text]
-
Chang, D. H., Osman, K., Connolly, J., Kukreja, A., Krasovsky, J., Pack, M., Hutchinson, A., Geller, M., Liu, N., Annable, R., Shay, J., Kirchhoff, K., Nishi, N., Ando, Y., Hayashi, K., Hassoun, H., Steinman, R. M., Dhodapkar, M. V.
(2005). Sustained expansion of NKT cells and antigen-specific T cells after injection of {alpha}-galactosyl-ceramide loaded mature dendritic cells in cancer patients. JEM
201: 1503-1517
[Abstract]
[Full Text]
-
Krueger, J G, Bowcock, A
(2005). Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis
64: ii30-ii36
[Abstract]
[Full Text]
-
Schnurr, M., Toy, T., Shin, A., Wagner, M., Cebon, J., Maraskovsky, E.
(2005). Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood
105: 1582-1589
[Abstract]
[Full Text]
-
Chamian, F., Lowes, M. A., Lin, S.-L., Lee, E., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Cardinale, I., Khatcherian, A., Novitskaya, I., Wittkowski, K. M., Krueger, J. G.
(2005). Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc. Natl. Acad. Sci. USA
102: 2075-2080
[Abstract]
[Full Text]